Rep. Carol D. Miller Purchases Shares of CME Group Inc. (NASDAQ:CME)

15 Apr 2025, 13:44 by Sarita Garza · The Markets Daily

Representative Carol D. Miller (R-West Virginia) recently bought shares of CME Group Inc. (NASDAQ:CME). In a filing disclosed on April 11th, the Representative disclosed that they had bought between $1,001 and $15,000 in CME Group stock on March 10th. The trade occurred in the Representative’s “MATT MILLER INVESTMENT MANAGEMENT ACCOUNT” account.

Representative Carol D. Miller also recently made the following trade(s):

Purchased $1,001 – $15,000 in shares of Aflac (NYSE:AFL) on 3/10/2025.
Purchased $1,001 – $15,000 in shares of Hershey (NYSE:HSY) on 3/10/2025.
Purchased $1,001 – $15,000 in shares of Gilead Sciences (NASDAQ:GILD) on 3/10/2025.
Sold $1,001 – $15,000 in shares of Pfizer (NYSE:PFE) on 3/10/2025.
Purchased $1,001 – $15,000 in shares of Lockheed Martin (NYSE:LMT) on 3/10/2025.
Purchased $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 3/10/2025.
Purchased $1,001 – $15,000 in shares of Honeywell International (NASDAQ:HON) on 3/10/2025.
Sold $1,001 – $15,000 in shares of U.S. Bancorp (NYSE:USB) on 3/10/2025.
Sold $1,001 – $15,000 in shares of Target (NYSE:TGT) on 3/10/2025.
Purchased $1,001 – $15,000 in shares of American Water Works (NYSE:AWK) on 3/10/2025.

CME Group Price Performance

NASDAQ:CME opened at $263.69 on Tuesday. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $273.42. The company has a market cap of $95.02 billion, a P/E ratio of 27.27, a P/E/G ratio of 6.76 and a beta of 0.43. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The stock’s 50-day simple moving average is $255.66 and its 200 day simple moving average is $239.56.

CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. As a group, sell-side analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were given a $1.25 dividend. The ex-dividend date was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a yield of 1.90%. This is an increase from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio (DPR) is 51.71%.

Wall Street Analysts Forecast Growth

CME has been the subject of a number of analyst reports. JPMorgan Chase & Co. lifted their price objective on shares of CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a research report on Thursday, February 13th. Citigroup cut CME Group from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Piper Sandler upped their price objective on CME Group from $275.00 to $283.00 and gave the company an “overweight” rating in a research note on Tuesday, April 8th. Keefe, Bruyette & Woods lifted their target price on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research note on Friday, February 14th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $269.00 price target on shares of CME Group in a research note on Thursday, April 3rd. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $247.47.

Check Out Our Latest Research Report on CME Group

Hedge Funds Weigh In On CME Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. SJS Investment Consulting Inc. grew its stake in CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after buying an additional 97 shares in the last quarter. New Age Alpha Advisors LLC boosted its position in shares of CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 43 shares in the last quarter. Financial Life Planners bought a new position in CME Group in the fourth quarter valued at approximately $32,000. Knuff & Co LLC acquired a new position in CME Group during the fourth quarter valued at approximately $33,000. Finally, Banque Transatlantique SA bought a new stake in CME Group during the fourth quarter worth $35,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at CME Group

In other CME Group news, Director Howard J. Siegel sold 10,000 shares of the business’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the sale, the director now owns 21,873 shares of the company’s stock, valued at approximately $5,686,980. The trade was a 31.37 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the transaction, the insider now owns 21,885 shares of the company’s stock, valued at $5,453,085.45. This trade represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 27,076 shares of company stock valued at $6,871,496. 0.30% of the stock is currently owned by corporate insiders.

About Representative Miller

Carol Miller (Republican Party) is a member of the U.S. House, representing West Virginia’s 1st Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

Miller (Republican Party) ran for re-election to the U.S. House to represent West Virginia’s 1st Congressional District. She won in the general election on November 5, 2024.

West Virginia’s 3rd Congressional District race was identified as a 2018 battleground that might have affected partisan control of the U.S. House in the 116th Congress. Incumbent Evan Jenkins (R) did not seek re-election in 2018, leaving the seat open. In the campaign, Miller emphasized her endorsement by President Donald Trump (R). Lara Trump, Senior Advisor to Donald J. Trump for President, Inc., said, “Carol is pro-coal, pro-Second Amendment, and pro-Trump through and through, and is prepared to tackle the opioid epidemic that’s affected countless West Virginians.” Miller also supported the construction of a wall on the southern U.S. border and the Tax Cuts and Jobs Act (TCJA).

Miller is a former Republican member of the West Virginia House of Delegates, representing District 16 from 2006 to 2018.

Miller has also worked in real estate and owns a bison farm.

Carol Miller was born in Columbus, Ohio. Miller graduated from Bexley High School in 1968. She earned a B.S. from Columbia College in 1972. Her career experience includes owning and operating Swann Ridge Bison Farm and working as a real estate manager.

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.